Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

382
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
382
Vaccinations01:51

Vaccinations

45.4K
Overview
45.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early-life gut microbiome-metabolome development trajectories in Chinese infants: a decentralized real-world evidence study.

Food & function·2026
Same author

UMI-guided single locus sequence typing method for phylotyping <i>Cutibacterium acnes</i> from skin samples.

Frontiers in cellular and infection microbiology·2026
Same author

Safety and immunogenicity of a cytomegalovirus (CMV) recombinant glycoprotein B (gB) vaccine in combination with polyacrylate or an emulsion-based adjuvants.

Vaccine·2026
Same author

RaMoA: Raman Microspectroscopy and Deep Learning for the Classification of Antimicrobial Mechanism of Action.

ACS infectious diseases·2026
Same author

HoloMoA: a holography and deep learning tool for the identification of antimicrobial mechanisms of action and the detection of novel MoA.

Frontiers in microbiology·2025
Same author

Diversity of immunization strongly impacts SARS-CoV-2 antibody function surrogates.

NPJ vaccines·2025
Same journal

Safety and immunogenicity of a COVID-19-Influenza Combination nanoparticle vaccine (CIC) containing SARS-CoV-2 recombinant spike and quadrivalent influenza hemagglutinin with Matrix-M® adjuvant: A phase 1/2 clinical trial.

Human vaccines & immunotherapeutics·2026
Same journal

Randomized controlled trial evaluating immunogenicity and safety of a porcine circovirus-free rotavirus vaccine in healthy Chinese infants.

Human vaccines & immunotherapeutics·2026
Same journal

Determinants of HPV vaccination acceptance among young adult women in Japan's catch-up generation: A cross-sectional study.

Human vaccines & immunotherapeutics·2026
Same journal

Spatial accessibility analysis of vaccination units in Gansu Province, China (2025).

Human vaccines & immunotherapeutics·2026
Same journal

Pneumococcal vaccination awareness and uptake among high-risk patients attending internal medicine outpatient clinics: A cross-sectional study.

Human vaccines & immunotherapeutics·2026
Same journal

How vaccine research took me on an international journey.

Human vaccines & immunotherapeutics·2026
See all related articles

Related Experiment Video

Updated: Sep 19, 2025

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.3K

Innovative micro physiological systems for vaccine development.

Kendra Reynaud1, Scott Atwell1, Christophe Védrine1

  • 1BIOASTER Technology Research Institute, Lyon, France.

Human Vaccines & Immunotherapeutics
|June 17, 2025
PubMed
Summary
This summary is machine-generated.

Micro Physiological Systems (MPS) offer human-relevant microenvironments for preclinical models. These advanced platforms are improving vaccine development by providing insights into immune responses and vaccine efficacy.

Keywords:
Micro physiological systemsbiomimeticimmunogenicityin vitropre-clinicalreactogenicitytranslationalvaccine

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.8K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.8K

Related Experiment Videos

Last Updated: Sep 19, 2025

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.3K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.8K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.8K

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Pharmacology

Background:

  • Micro Physiological Systems (MPS) are in vitro biomimetic platforms recreating human organ and tissue complexity.
  • MPS address translational limitations in preclinical models by offering human-relevant microenvironments.
  • Existing MPS models have shown potential in vaccine development, yielding results applicable to human trials.

Purpose of the Study:

  • To highlight the utility of Micro Physiological Systems (MPS) in enhancing vaccine development pipelines.
  • To showcase how MPS can overcome translational barriers in preclinical research.
  • To explore the potential of emerging MPS devices in vaccine research.

Main Methods:

  • Utilizing static MPS platforms to model peripheral and lymphoid tissues for studying vaccination responses.
  • Employing dynamic flow lymphoid-follicle-on-chip devices to assess antigen-specific antibody production.
  • Investigating the interplay between vaccine reactogenicity and innate immune stimulation.

Main Results:

  • MPS platforms have successfully modeled immune responses to vaccination, providing human-relevant data.
  • Dynamic flow MPS have demonstrated the capacity to generate antigen-specific antibodies.
  • Emerging MPS technologies are poised to elucidate inflammatory profiles of vaccine targets.

Conclusions:

  • Micro Physiological Systems (MPS) are valuable tools for advancing vaccine development and improving preclinical research.
  • MPS offer a human-relevant in vitro approach to assess vaccine efficacy and safety.
  • Future MPS applications may derisk vaccine targets by analyzing inflammatory profiles before clinical trials.